Propolis Lozenges Extract and Their Effect on Salivary Biomarkers and on Oral Health Condition in (19_24) Years Old
Launched by AL-MUSTANSIRIYAH UNIVERSITY · Mar 15, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
100 subjects will be enrolled, who show generalized gingivitis (moderate gingivitis) with no Periodontal pocket depth\>3 mm, intact periodontium, and no loss of periodontal attachment), caused by the accumulation of plaque. 50 subjects are case that given a lozenge containing propolis and oral hygiene instructions, and 50 subjects were control that were given oral hygiene instructions only. The participants will be asked to chew a lozenge twice per day and Discontinuation of the lozenges will be advised in cases of any allergic reaction. in baseline visit at the beginning, Saliva collection...
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Age of patients (19_24) who volunteered to participate.
- • 2. Apparently, good general health. With no systemic diseases.
- • 3. plaque and gingival indices were ranged from (1.1_2.0)
- Exclusion Criteria:
- • 1. Individuals with chronic illnesses, immunocompromised individuals, pregnant women, those on contraceptive medications, and breastfeeding mothers.
- • 2. People who use mouthwash at the moment or any preventive modalities. 3. Those taking anti-inflammatory drugs and antibiotics both during the study and in the final four weeks prior.
- • 4. Individuals have a history of hypersensitivity to any substance utilized in the current investigation.
- • 5. Individuals who have undergone a recent tooth extraction. 6. Individuals with Periodontal pocket depth Equal or less than 4 or attachment loss.
- • 7. Individuals who smoke. 8. Individuals with orthodontic equipment, removable dentures, implants.
About Al Mustansiriyah University
Al-Mustansiriyah University is a prominent academic institution located in Baghdad, Iraq, dedicated to advancing education, research, and healthcare. As a clinical trial sponsor, the university leverages its expertise in medical and scientific research to facilitate innovative studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a commitment to ethical standards and rigorous scientific methodologies, Al-Mustansiriyah University collaborates with healthcare professionals, researchers, and regulatory bodies to ensure the integrity and reliability of its clinical trials, ultimately striving to enhance public health and advance medical practices within the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baghdad, , Iraq
Patients applied
Trial Officials
ahmed s aljanaby, B.D.S
Principal Investigator
Al-Mustansiriyah University
mohammed K Mahmoud, M.S.C
Study Director
Al-Mustansiriyah University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported